202 related articles for article (PubMed ID: 29284499)
41. Characteristics of left atrial remodeling in patients with atrial fibrillation and hypertrophic cardiomyopathy in comparison to patients without hypertrophy.
Nedios S; Dinov B; Seewöster T; Lindemann F; Richter S; Arya A; Dagres N; Husser D; Bollmann A; Hindricks G; Müssigbrodt A
Sci Rep; 2021 Jun; 11(1):12411. PubMed ID: 34127728
[TBL] [Abstract][Full Text] [Related]
42. Prognostic implications of global myocardial mechanics in hypertrophic cardiomyopathy by cardiovascular magnetic resonance feature tracking. Relations to left ventricular hypertrophy and fibrosis.
Hinojar R; Fernández-Golfín C; González-Gómez A; Rincón LM; Plaza-Martin M; Casas E; García-Martín A; Fernandez-Mendez MA; Esteban A; Nacher JJJ; Zamorano JL
Int J Cardiol; 2017 Dec; 249():467-472. PubMed ID: 29121751
[TBL] [Abstract][Full Text] [Related]
43. Atrial Mechanics in Hypertrophic Cardiomyopathy: Discriminating between Ventricular Hypertrophy and Fibrosis.
Marques-Alves P; Ferreira JA; Freitas AA; Almeida JP; Baptista R; Castro G; Martins R; Donato P; Ferreira MJ; Gonçalves L
Arq Bras Cardiol; 2022 Jan; 118(1):77-87. PubMed ID: 35195213
[TBL] [Abstract][Full Text] [Related]
44. Relationship of basal-septal fibrosis with LV outflow tract obstruction in hypertrophic cardiomyopathy: insights from cardiac magnetic resonance analysis.
Nakamura T; Iwanaga Y; Yasuda M; Kawamura T; Miyaji Y; Morooka H; Miyazaki S
Int J Cardiovasc Imaging; 2016 Apr; 32(4):613-20. PubMed ID: 26589516
[TBL] [Abstract][Full Text] [Related]
45. Cardiac Magnetic Resonance Feature-Tracking Identifies Preclinical Abnormalities in Hypertrophic Cardiomyopathy Sarcomere Gene Mutation Carriers.
Negri F; Sanna GD; Di Giovanna G; Cittar M; Grilli G; De Luca A; Dal Ferro M; Baracchini N; Burelli M; Paldino A; Del Franco A; Pradella S; Todiere G; Olivotto I; Imazio M; Sinagra G; Merlo M
Circ Cardiovasc Imaging; 2024 Apr; 17(4):e016042. PubMed ID: 38563190
[TBL] [Abstract][Full Text] [Related]
46. Degree and distribution of left ventricular hypertrophy as a determining factor for elevated natriuretic peptide levels in patients with hypertrophic cardiomyopathy: insights from cardiac magnetic resonance imaging.
Park JR; Choi JO; Han HJ; Chang SA; Park SJ; Lee SC; Choe YH; Park SW; Oh JK
Int J Cardiovasc Imaging; 2012 Apr; 28(4):763-72. PubMed ID: 21516440
[TBL] [Abstract][Full Text] [Related]
47. Effect of sarcomere and mitochondria-related mutations on myocardial fibrosis in patients with hypertrophic cardiomyopathy.
Chung H; Kim Y; Park CH; Kim JY; Min PK; Yoon YW; Kim TH; Lee BK; Hong BK; Rim SJ; Kwon HM; Lee KA; Choi EY
J Cardiovasc Magn Reson; 2021 Mar; 23(1):18. PubMed ID: 33658040
[TBL] [Abstract][Full Text] [Related]
48. Difference in left atrial myocardial dynamics during reservoir phase between hypertrophic cardiomyopathy and hypertensive heart determined using three-dimensional speckle tracking echocardiography.
Yanagi Y; Okada K; Kaga S; Mikami T; Aiba M; Masauzi N; Murayama M; Tanemura A; Yokoyama S; Nishino H; Nakabachi M; Tamaki Y; Aoyagi H; Motoi K; Ishizaka S; Chiba Y; Tsujinaga S; Iwano H; Anzai T
Int J Cardiovasc Imaging; 2022 Aug; 38(8):1781-1791. PubMed ID: 37726515
[TBL] [Abstract][Full Text] [Related]
49. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
Yin L; Xu HY; Zheng SS; Zhu Y; Xiao JX; Zhou W; Yu SS; Gong LG
Int J Cardiovasc Imaging; 2017 Dec; 33(12):1949-1959. PubMed ID: 28612277
[TBL] [Abstract][Full Text] [Related]
50. Early segmental relaxation abnormalities in hypertrophic cardiomyopathy for differential diagnostic of patients with left ventricular hypertrophy.
Voigt C; Münch J; Avanesov M; Suling A; Witzel K; Lund G; Patten M
Clin Cardiol; 2017 Nov; 40(11):1026-1032. PubMed ID: 28741295
[TBL] [Abstract][Full Text] [Related]
51. Prognostic value of fast semi-automated left atrial long-axis strain analysis in hypertrophic cardiomyopathy.
Yang F; Wang L; Wang J; Pu L; Xu Y; Li W; Wan K; Yang D; Sun J; Han Y; Zhu Y; Chen Y
J Cardiovasc Magn Reson; 2021 Mar; 23(1):36. PubMed ID: 33761947
[TBL] [Abstract][Full Text] [Related]
52. Left atrial dysfunction may precede left atrial enlargement and abnormal left ventricular longitudinal function: a cardiac MR feature tracking study.
Zhou D; Yang W; Yang Y; Yin G; Li S; Zhuang B; Xu J; He J; Wu W; Jiang Y; Sun X; Wang Y; Sirajuddin A; Zhao S; Lu M
BMC Cardiovasc Disord; 2022 Mar; 22(1):99. PubMed ID: 35282817
[TBL] [Abstract][Full Text] [Related]
53. Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction.
Ellims AH; Iles LM; Ling LH; Hare JL; Kaye DM; Taylor AJ
J Cardiovasc Magn Reson; 2012 Oct; 14(1):76. PubMed ID: 23107451
[TBL] [Abstract][Full Text] [Related]
54. Electrocardiographic features of sarcomere mutation carriers with and without clinically overt hypertrophic cardiomyopathy.
Lakdawala NK; Thune JJ; Maron BJ; Cirino AL; Havndrup O; Bundgaard H; Christiansen M; Carlsen CM; Dorval JF; Kwong RY; Colan SD; Køber LV; Ho CY
Am J Cardiol; 2011 Dec; 108(11):1606-13. PubMed ID: 21943931
[TBL] [Abstract][Full Text] [Related]
55. Hypertrophic cardiomyopathy in myosin-binding protein C (
Adalsteinsdottir B; Burke M; Maron BJ; Danielsen R; Lopez B; Diez J; Jarolim P; Seidman J; Seidman CE; Ho CY; Gunnarsson GT
Open Heart; 2020; 7(1):e001220. PubMed ID: 32341788
[TBL] [Abstract][Full Text] [Related]
56. Left ventricular remodeling in hypertrophic cardiomyopathy patients with atrial fibrillation.
Tian H; Cui J; Yang C; Hu F; Yuan J; Liu S; Yang W; Jiang X; Qiao S
BMC Cardiovasc Disord; 2018 Nov; 18(1):207. PubMed ID: 30390664
[TBL] [Abstract][Full Text] [Related]
57. Mitral annular plane systolic excursion is an easy tool for fibrosis detection by late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
Doesch C; Sperb A; Sudarski S; Lossnitzer D; Rudic B; Tülümen E; Heggemann F; Schimpf R; Schoenberg SO; Borggrefe M; Papavassiliu T
Arch Cardiovasc Dis; 2015; 108(6-7):356-66. PubMed ID: 25863428
[TBL] [Abstract][Full Text] [Related]
58. Biatrial performance in children with hypertrophic cardiomyopathy: CMR study.
Mazurkiewicz Ł; Ziółkowska L; Petryka J; Śpiewak M; Małek Ł; Kubik A; Marczak M; Misko J; Brzezińska-Rajszys G
Eur Radiol; 2018 Dec; 28(12):5148-5159. PubMed ID: 29882072
[TBL] [Abstract][Full Text] [Related]
59. Left atrial function and phenotypes in asymmetric hypertrophic cardiomyopathy.
Kobayashi Y; Wheeler M; Finocchiaro G; Ariyama M; Kobayashi Y; Perez MV; Liang D; Kuznetsova T; Schnittger I; Ashley E; Haddad F
Echocardiography; 2017 Jun; 34(6):843-850. PubMed ID: 28370331
[TBL] [Abstract][Full Text] [Related]
60. Myocardial fibrosis in patients with symptomatic obstructive hypertrophic cardiomyopathy: correlation with echocardiographic measurements, sarcomeric genotypes, and pro-left ventricular hypertrophy polymorphisms involving the renin-angiotensin-aldosterone system.
Blauwet LA; Ackerman MJ; Edwards WD; Riehle DL; Ommen SR
Cardiovasc Pathol; 2009; 18(5):262-8. PubMed ID: 18835191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
